Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptics differentially modulate central dopamine D1-receptor binding

A E Johnson1, H Coirini, L Källström

  • 1Department of Psychiatry, University Hospital, Uppsala University, Sweden.

Neuroreport
|April 19, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathy.

Neurobiology of disease·2025
Same author

Case of Hydrops Amnii.

The Chicago medical journal·2023
Same author

Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats.

Domestic animal endocrinology·2020
Same author

The Mars 2020 Engineering Cameras and Microphone on the Perseverance Rover: A Next-Generation Imaging System for Mars Exploration.

Space science reviews·2020
Same author

Effect of Pre-Cure Freezing and Thawing on the Microflora, Fat Characteristics and Palatability of Dry-Cured Ham <sup>1</sup>.

Journal of food protection·2019
Same author

Effects of Pre-cure Storage and Smoking on the Microflora and Palatability of Aged Dry-cured Hams <sup>1</sup>.

Journal of food protection·2019

Long-term fluphenazine treatment alters dopamine D1-receptor binding in the basal ganglia. While binding decreased in some areas, it increased in the entopeduncular nucleus, suggesting novel neuroleptic mechanisms.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurobiology

Background:

  • Classical neuroleptics, such as fluphenazine, are primarily known for modulating dopamine D1-receptor function in the striatum.
  • The long-term effects of neuroleptic treatment on dopamine receptor binding across different basal ganglia regions remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of chronic fluphenazine administration on dopamine D1-receptor binding in distinct basal ganglia nuclei.
  • To determine if observed changes in receptor binding are due to alterations in receptor affinity or density.

Main Methods:

  • Radioligand binding assays using [125I]SCH-23982 to quantify dopamine D1-receptor binding.
  • Analysis of receptor binding in specific basal ganglia regions, including the caudate putamen, nucleus accumbens, olfactory tubercle, and entopeduncular nucleus.

Related Experiment Videos

  • Competition binding studies to assess the affinity of fluphenazine and other dopamine ligands for D1-binding sites.

    • Main Results:

    • Eighteen months of fluphenazine treatment significantly reduced [125I]SCH-23982 binding in the caudate putamen, nucleus accumbens, and olfactory tubercle.
    • Conversely, fluphenazine exposure led to enhanced [125I]SCH-23982 binding in the entopeduncular nucleus.
    • Competition studies confirmed that these region-dependent changes were not attributable to alterations in ligand affinity for D1-receptors.

    Conclusions:

    • Classical neuroleptics like fluphenazine induce region-specific alterations in dopamine D1-receptor binding within the basal ganglia.
    • Neuroleptic treatment may enhance neurotransmission in the entopeduncular nucleus by increasing dopamine D1-receptor binding, in addition to modulating striatal function.
    • These findings suggest a more complex mechanism of action for classical neuroleptics in the basal ganglia than previously recognized.